Sign in

CIK 0001607678

  • Large accelerated filer

Viking Therapeutics, Inc.

Sign in to watch
Ticker
VKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
461073877
Phone
+1 858-704-4660
Business address
9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
  1. 4 Planned sale Director sold 25,000 shares at $28.05 ($701,250)
  2. 4 Planned sale President & CEO sold 85,000 shares at an average $24.71 ($2,100,750)
  3. 4 Planned sale President & CEO sold 35,000 shares at $23.95 ($838,250)
  4. 4 Planned sale Director sold 30,000 shares at $23.05 ($691,500)
  5. 4 Shares withheld for taxes President & CEO gave up 254,192 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Operating Officer gave up 63,409 shares (to pay taxes)
  7. 4 Open-market sale Chief Financial Officer sold 15,000 shares at $17.90 ($268,500)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market sale Director sold 40,000 shares at $25.00 ($1,000,000)
  14. 4 Open-market sale Director sold 16,000 shares at $24.00 ($384,000)
  15. 4 Open-market sale President & CEO sold 45,000 shares at $22.45 ($1,010,250)
  16. 4 Open-market sale Director sold 16,000 shares at $22.00 ($352,061)
  17. 4 Open-market sale President & CEO sold 35,000 shares at $21.45 ($750,750)
  18. 4 Open-market sale Director sold 20,786 shares at $20.00 ($415,720)
  19. 4 Open-market sale President & CEO sold 155,000 shares at $20.45 ($3,169,766)
  20. 4 Open-market sale Chief Operating Officer sold 12,500 shares at $20.00 ($250,000)

Page 4 of 11 · 216 filings